IP: Inequitable conduct post-<em>Therasense</em>
Yet, despite the overall decline of inequitable conduct, some courts have still upheld the defense, leaving a bitter reminder that the doctrine tenaciously clings to life.
August 13, 2013 at 08:36 AM
4 minute read
The original version of this story was published on Law.com
Dubbing the defense of “inequitable conduct” (which renders an entire patent unenforceable) a “plague” on the patent system, the Federal Circuit, in its 2011 en banc opinion in Therasense Inc. v. Becton, tightened the legal standards for proving the defense to require clear and convincing evidence that:
- An individual associated with the prosecution of a patent application made an affirmative misrepresentation of a material fact, failed to disclose material information or submitted false material information to the patent office
- The individual did so with a specific intent to deceive the patent examiner into granting the patent.
The court held that the materiality of the information must be “but for” —i.e., had the information been disclosed, the patent would not have been allowed. After Therasense, some in the patent community proclaimed that the demise of the defense was inevitable.
And, to be sure, there has been a general decline in the prevalence and success of inequitable conduct defenses since the decision. The district courts also have increasingly been willing to grant motions to dismiss or strike inequitable conduct defenses at the pleadings stage.
Yet, despite the overall decline of inequitable conduct, some courts have still upheld the defense, leaving a bitter reminder that the doctrine tenaciously clings to life.
For example, as recently as July 18, Judge Kronstadt of the Central District of California, following a bench trial, accepted the defense and held the patent unenforceable. The court's decision highlights some of the landmines that still exist for inequitable conduct defenses that survive the pleadings stage.
The court's ruling is particularly troubling from a patent owner's perspective because certain claims of the patent had already been found invalid and not infringed. On this point, the court explained that “[t]he question of inequitable conduct in the procurement of the patent is relevant even after a patent is found invalid, because it bears on the question whether the case is 'exceptional' for purposes of attorney fees under 35 U.S.C. § 285.”
The court then ordered the defendant to submit an application for the portion of its attorney fees that related to the alleged misconduct during patent prosecution. For defendants that are hesitant to plead inequitable conduct post-Therasense, the chance to succeed on an exceptional case claim and the court's invitation to the defendant to apply for attorney fees as a result of inequitable conduct is just the type of motivation that could encourage more defendants to take on the uphill battle of this defense.
The Laube decision also demonstrates the continued importance of witness performance in connection with responding to an inequitable conduct defense. The court focused much of its analysis on the testimony provided by the inventor, critiquing both the substance and the believability of that testimony. The court concluded, “based on the content of Laube's testimony as well as his demeanor and the tone and manner in which it was presented,” that “Laube deliberately withheld the [undisclosed prior art] from [the prosecuting attorney.]” As to materiality, the court found that the undisclosed prior art demonstrated the very feature that Laube had argued was missing from the prior art, and that it was this missing feature that led the examiner to allow the claims of the asserted patent.
Inequitable conduct has also gotten the attention of the Supreme Court, where there is currently a petition for certiorari pending in Sony Computer Entm't Am. LLC v. 1st Media, LLC. The question presented is whether the Federal Circuit erred in “restricting district courts' equitable discretion in evaluating unenforceability,” with the Petitioner complaining that the current test is too “rigid.” The Supreme Court has invited the Solicitor General to file a brief expressing the views of the U.S., so this case remains one to watch.
The bottom line is that the defense of inequitable conduct, while significantly restricted, remains very much a reality. Patentees should continue to consider the potential for this defense both in pre-litigation diligence and as litigation unfolds. In this way, the patentee can avoid the situation where a surprised witness makes unfortunate or even incorrect statements during deposition that are difficult to explain later, or raise credibility problems when the witness does try to explain. For accused infringers, the defense remains in their armamentarium to be launched in appropriate circumstances. Given the strict legal standards, however, to be successful the accused infringer will need to build the defense carefully and persuasively.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllAre Corporate Counsel Ready for Election Risks, at Polls and Beyond?
GC Who Helped Fanatics Pull Off Growth Tear Joins Acquisitive Provider of Live Event Logistics
After Recasting ACC Into Global Enterprise, CEO Veta Richardson Plans 2025 Exit
Trending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 3GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5Monsanto Moves to Pause PCB Trial That Starts This Week
Who Got The Work
Blank Rome partner Andrew T. Hambelton has stepped in to defend Fragrancenet.com in a pending trademark infringement lawsuit. The case, filed Aug. 29 in New York Southern District Court by the Blakely Law Group, targets the defendants for allegedly selling counterfeit fragrance products. The case, assigned to U.S. District Judge Lorna G. Schofield, is 1:24-cv-06521, Abercrombie & Fitch Trading Co. v. Quester (US) Enterprises, Inc. et al.
Who Got The Work
Davis Polk & Wardwell partners Mari Grace and Edmund Polubinski III have entered appearances for Australia-based Bitcoin-mining company Iris Energy and other defendants in a pending securities class action. The action, filed Oct. 7 in New York Eastern District Court by the Rosen Law Firm, contends that the defendants concealed the inadequacy of the company's site in Childress County, Texas, including it being 'ill-equipped' and unable to operate the company's proprietary design. The case, assigned to U.S. District Judge Peggy Kuo, is 1:24-cv-07046, Williams-Israel v. Iris Energy Limited et al.
Who Got The Work
Ryan S. Stippich of Reinhart Boerner Van Deuren has entered an appearance for biopharmaceutical company Veru Inc. and other defendants in a pending shareholder derivative lawsuit. The action, filed Sept. 30 in Wisconsin Western District Court by the Brown Law Firm on behalf of June Ovadias, accuses the defendant of failing to disclose that small sample sizes and other issues rendered it unlikely that the FDA would grant Emergency Use Authorization for the cancer drug candidate sabizabulin as a potential treatment for COVID-19. The case, assigned to U.S. District Judge William M. Conley, is 3:24-cv-00676, Ovadias, June v. Steiner, Mitchell et al.
Who Got The Work
Holland & Knight partners Cynthia A. Gierhart and Thomas Willcox Brooke have entered appearances for Pakistani American Political Action Committee and Rao Kamran Ali in a pending trademark infringement lawsuit. The action, filed Sept. 24 in District of Columbia District Court by Jackson Walker on behalf of Pakistani American Public Affairs Committee, accuses the defendants of using a mark that's confusingly similar to the plaintiff's 'Pak-Pac' marks without authorization. The case, assigned to U.S. District Judge Randolph D. Moss, is 1:24-cv-02727, Pakistani American Public Affairs Committee v. Pakistani American Political Action Committee et al.
Who Got The Work
Lauren M. Rosenberg and Yonatan Even of Cravath, Swaine & Moore have stepped in to represent Israel-based Oddity Tech Ltd. in a pending securities class action. The case, filed Aug. 30 in New York Southern District Court by Pomerantz LLP and Holzer & Holzer, contends that the defendant made materially misleading statements regarding the capability of Oddity's AI technology and ongoing civil litigation, resulting in the artifical inflation of the market price of Oddity's securities. The case, assigned to U.S. District Judge Margaret M. Garnett, is 1:24-cv-06571, Hoare v. Oddity Tech Ltd. et al.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250